Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 2021-11-23

ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes

Department of Functional Sciences, University of Medicine and Pharmacy “Carol Davila” Bucharest, Romania
ACE2, SARS-CoV-2, COVID-19, enzymatic activity, enzymatic promiscuity, TMPRSS2, ADAM-17, Romania

Abstract

The SARS-CoV-2 is an RNA B type β-coronavirus that distinguishes itself from previous coronaviruses by its high infectivity and mortality rates. The mechanism of viral entry into the host cell via ACE2 is currently under research. Several proteases have been nominated to activate the virus but identifying the exact enzyme/enzymes is missing.   Moreover, recent work suggests that TMPRSS2 cannot be the enzyme to cleave the SARS-CoV-2 spike or that multiple proteases contribute to SARS-CoV-2 activation. The multitude of proteases that have been nominated to activate the virus suggests that the consensual identification of the precise, key enzyme is still missing. In this context, we synthesize the current controversies regarding the putative enzymes involved in SARS-CoV-2 infectivity and analyze whether ACE2 could have unexpected enzymatic roles in this process, besides its acknowledged receptor role. We hypothesize that ACE2 plays an enzymatic role as well in SARS-CoV-2 activation. Understanding the exact roles of ACE2 in COVID-19 is capital for the future design of specific, efficient therapies and deserves dedicated research. Our conviction is therefore not "if", “but” "when" will the researchers start to wonder about what is hidden behind the apparent only role of ACE2 as a receptor for SARS-CoV-2.



Downloads

Download data is not yet available.


How to Cite

1.
Lazar AM. ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes. jidhealth [Internet]. 2021 Nov. 23 [cited 2022 Aug. 15];4(4):581-7. Available from: https://jidhealth.com/index.php/jidhealth/article/view/169